Skip to main content

and
  1. Article

    Open Access

    Clinical implementation of RNA sequencing for Mendelian disease diagnostics

    Lack of functional evidence hampers variant interpretation, leaving a large proportion of individuals with a suspected Mendelian disorder without genetic diagnosis after whole genome or whole exome sequencing ...

    Vicente A. Yépez, Mirjana Gusic, Robert Kopajtich, Christian Mertes in Genome Medicine (2022)

  2. Article

    Open Access

    Correction to: The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency

    A Correction to this paper has been published: https://doi.org/10.1007/s00109-021-02057-3

    Felix Distelmaier, Henk-Jan Visch, Jan A. M. Smeitink in Journal of Molecular Medicine (2021)

  3. No Access

    Chapter

    Mitochondrial Symptomatic Treatments

    Based on improvements in diagnostic strategies, the group of genetically defined mitochondrial diseases is rapidly growing. This advances our understanding of the underlying pathophysiology and is important fo...

    Felix Distelmaier, Thomas Klopstock in Diagnosis and Management of Mitochondrial Disorders (2019)

  4. No Access

    Article

    Severe ichthyosis in MPDU1-CDG

    Congenital disorders of glycosylation (CDG) have a broad spectrum of clinical manifestations. They can affect multiple organ systems, including skin and subcutaneous tissue. We report on an infant with severe ...

    Christian Thiel, Saskia Wortmann in Journal of Inherited Metabolic Disease (2018)

  5. Article

    Open Access

    Challenges of palliative care in children with inborn metabolic diseases

    Our objective was to evaluate children with metabolic diseases in paediatric palliative home care (PPC) and the process of decision-making. This study was conducted as single-centre retrospective cohort study ...

    Jessica I. Hoell, Jens Warfsmann, Felix Distelmaier in Orphanet Journal of Rare Diseases (2018)

  6. Article

    Open Access

    A scoring system predicting the clinical course of CLPB defect based on the foetal and neonatal presentation of 31 patients

    Recently, CLPB deficiency has been shown to cause a genetic syndrome with cataracts, neutropenia, and 3-methylglutaconic aciduria. Surprisingly, the neurological presentation ranges from completely unaffected ...

    Ewa Pronicka, Mariola Ropacka-Lesiak in Journal of Inherited Metabolic Disease (2017)

  7. No Access

    Article

    Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts

    Acute liver failure (ALF) in infancy and childhood is a life-threatening emergency and in about 50 % the etiology remains unknown. Recently biallelic mutations in NBAS were identified as a new molecular cause of ...

    Christian Staufner, Tobias B. Haack in Journal of Inherited Metabolic Disease (2016)

  8. No Access

    Article

    MRPL44 mutations cause a slowly progressive multisystem disease with childhood-onset hypertrophic cardiomyopathy

    Defects in mitochondrial translation may lead to combined respiratory chain deficiency and typically cause childhood-onset multisystem disease. Only recently, a homozygous missense mutation (c.467T > G, p.Leu1...

    Felix Distelmaier, Tobias B. Haack, Claudia B. Catarino in neurogenetics (2015)

  9. No Access

    Article

    Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations

    FBXL4 deficiency is a recently described disorder of mitochondrial maintenance associated with a loss of mitochondrial DNA in cells. To date, the genetic diagnosis of FBXL4 deficiency has...

    Martina Huemer, Daniela Karall, Anna Schossig in Journal of Inherited Metabolic Disease (2015)

  10. No Access

    Article

    MRPS22 mutation causes fatal neonatal lactic acidosis with brain and heart abnormalities

    The mitochondrial ribosomes are required for the synthesis of mitochondrial DNA-encoded subunits of the oxidative phosphorylation (OXPHOS) system. Here, we present a neonate with fatal lactic acidosis and comb...

    Fabian Baertling, Tobias B. Haack, Richard J. Rodenburg, Jörg Schaper in neurogenetics (2015)

  11. No Access

    Article

    Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease

    The mitochondrial pyruvate oxidation route is a tightly regulated process, which is essential for aerobic cellular energy production. Disruption of this pathway may lead to severe neurometabolic disorders with...

    Katharina Danhauser, Jan A. M. Smeitink in Journal of Inherited Metabolic Disease (2015)

  12. No Access

    Chapter

    Biotin-Responsive Basal Ganglia Disease: A Treatable Differential Diagnosis of Leigh Syndrome

    Biotin-responsive basal ganglia disease (BBGD) is an autosomal recessive disorder, which is caused by mutations in the SLC19A3 gene. BBGD typically causes (sub)acute episodes with encephalopathy and subsequent ne...

    Felix Distelmaier, Peter Huppke in JIMD Reports - Case and Research Reports, … (2014)

  13. No Access

    Article

    Hypertrichosis in presymptomatic mitochondrial disease

    Leigh syndrome is a neurometabolic disorder commonly associated with disturbed oxidative phosphorylation, which leads to bilateral symmetric necrotizing lesions in the central nervous system. Neurological symp...

    Fabian Baertling, Ertan Mayatepek in Journal of Inherited Metabolic Disease (2013)

  14. Article

    Open Access

    The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency

    Malfunction of mitochondrial complex I caused by nuclear gene mutations causes early-onset neurodegenerative diseases. Previous work using cultured fibroblasts of complex-I-deficient patients revealed elevated...

    Felix Distelmaier, Henk-Jan Visch, Jan A. M. Smeitink in Journal of Molecular Medicine (2009)